1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Brain Scientific Inc.

Brain Scientific Inc.

BRSF
Brain Scientific Inc.US flagOther OTC
0.00
USD
- -
- -
746.00Market Cap
2021 Y
2022 Y
TTM
Revenue per Share
0.73
- -
0.25
Basic EPS, GAAP
-25.11
- -
-14.5
Free Cash Flow per Basic Share
-16.35
- -
-7.01
Dividend per Share
- -
- -
- -
Book Value per Share
-61.47
- -
-40.67
Tangible Book Value per Share
-34.57
- -
-6.85
Basic Weighted Avg Shares
- -
- -
1
Sales/Revenue/Turnover
- -
- -
- -
Operating Margin (%)
-3,257.41
-4,478.11
-4,478.11
Depreciation Expense
- -
1
1
Net Income, GAAP
-9
-12
-12
Effective Tax Rate (%)
- -
- -
- -
Profit Margin (%)
-3,424.57
-5,753
-5,753
Working Capital
-3
-6
-6
LT Debt
10
- -
- -
Total Equity
-1
4
4
Return on Invested Capital (%)
- -
- -
- -
Return on Capital (%)
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Jun'22
Sep'22
Dec'22
ST Debt
2
2
3
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1
1
1
Market Capitalization
9
8
- -

Working Capital

FRC

•

in mil. unless spec.
Jun'22
Sep'22
Dec'22
Total Current Assets
4
2
1
Cash, Cash Equivalents & STI
4
2
1
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
7
7
7
Payables & Accruals
3
3
3
ST Debt
2
2
3
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-721.24%
Free Cash Flow
- -
- -
0.72%
Net Income, GAAP
- -
- -
35.64%
Sales/Revenue/Turnover
- -
- -
-19.26%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
-1.1
-1.88
-3.03
- -
- -
2021
- -
- -
- -
- -
-25.11
2022
-3.63
-3.5
-3.58
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Hassan Kotob
Full Time Employees
11
Sector
Healthcare
Industry
Medical - Devices
Address
6700 Professional Parkway Sarasota FL United States of America 34240
IPO Date
Jan 8, 2021
CIK
0001662382
Website
brainscientific.com
Similar Companies
Siemens Healthineers AG (SHL.DE)
Medimaging Integrated Solution Inc. (6796.TW)
AVDR US LargeCap Leading ETF (AVDR)
Artivion, Inc. (AORT)
ATS Medical, Inc. (ATSI)
Visiomed Group (VMGBS.PA)
Business
Brain Scientific Inc. (BRSF), a medtech company founded in 2013 and headquartered in Sarasota, Florida, develops and provides neurology-focused medical devices and motion products in the United States and internationally; its core offerings include the NeuroCap, a disposable soft layered cap with an integrated electrode circuit designed to address limitations of conventional electroencephalography (EEG) systems, the NeuroEEG amplifier and desktop software for storing and analyzing data captured from the NeuroCap, piezoelectric motors through its PiezoMotion subsidiary, and the NeuroHub platform under development to enable remote access to patient and clinical data for evaluating neurological conditions. These products support EEG recording in diverse settings such as neurology clinics, emergency departments, ICUs, urgent care facilities, nursing homes, assisted living centers, sports facilities, and remote clinical research studies, targeting healthcare providers, hospitals, and research institutions with affordable, easy-to-use solutions that combine hardware, software, and cloud-based telehealth services. Recent developments encompass strategic distribution partnerships, including with SysteMedic and MVAP Medical Supplies to expand global market access for its wearable EEG technologies, alongside ongoing efforts to modernize brain diagnostics amid a low-revenue base of approximately $215,000 and persistent operational challenges under CEO Hassan Kotob.

Company News

APIChatGPT

  • proactiveinvestors.ca

    Tiziana Life Sciences presents intranasal foralumab at Preserving the Brain scientific conference in Italy

  • globenewswire.com

    Brain Scientific and Piezo Motion Complete Merger and Announce Hassan Kotob as CEO of the Combined Company

  • globenewswire.com

    Brain Scientific Enters into Merger Agreement with Piezo Motion

  • globenewswire.com

    Brain Scientific Featured in Syndicated Broadcast Covering Receipt of FDA Clearance for Next-Gen NeuroCap EEG Headset

  • globenewswire.com

    Brain Scientific Announces FDA Clearance for Next-Gen NeuroCap™ EEG Headset